These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7896490)

  • 1. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin.
    Schmidt JB; Binder M; Macheiner W; Bieglmayer C
    Int J Dermatol; 1995 Jan; 34(1):53-7. PubMed ID: 7896490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tretinoin-iontophoresis in atrophic acne scars.
    Schmidt JB; Donath P; Hannes J; Perl S; Neumayer R; Reiner A
    Int J Dermatol; 1999 Feb; 38(2):149-53. PubMed ID: 10192170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flattening of atrophic acne scars by using tretinoin by iontophoresis.
    Knor T
    Acta Dermatovenerol Croat; 2004; 12(2):84-91. PubMed ID: 15075042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
    Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
    J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of Atrophic Acne Scars in Skin of Color Using Topical Synthetic Epidermal Growth Factor (EGF) Serum: A Pilot Study.
    Stoddard MA; Herrmann J; Moy L; Moy R
    J Drugs Dermatol; 2017 Apr; 16(4):322-326. PubMed ID: 28403265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
    J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in Atrophic Acne Scars Using Topical Synthetic Epidermal Growth Factor (EGF) Serum: A Pilot Study.
    Seidel R; Moy RL
    J Drugs Dermatol; 2015 Sep; 14(9):1005-10. PubMed ID: 26355620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
    Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
    Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
    Leyden JJ; Tanghetti EA; Miller B; Ung M; Berson D; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):12-9. PubMed ID: 12095064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical management of acne scars: The uncharted terrain.
    Bikash C; Sarkar R
    J Cosmet Dermatol; 2023 Apr; 22(4):1191-1196. PubMed ID: 36606377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant alternative treatment with chemical peeling and subsequent iontophoresis for postinflammatory hyperpigmentation, erosion with inflamed red papules and non-inflamed atrophic scars in acne vulgaris.
    Kurokawa I; Oiso N; Kawada A
    J Dermatol; 2017 Apr; 44(4):401-405. PubMed ID: 27743393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis from retinoic acid.
    Balato N; Patruno C; Lembo G; Cuccurullo FM; Ayala F
    Contact Dermatitis; 1995 Jan; 32(1):51. PubMed ID: 7720378
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies of the treatment of facial atrophic acne scars and acne with a bipolar fractional radiofrequency system.
    Kaminaka C; Uede M; Matsunaka H; Furukawa F; Yamamoto Y
    J Dermatol; 2015 Jun; 42(6):580-7. PubMed ID: 25855397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin.
    Katsambas A; Graupe K; Stratigos J
    Acta Derm Venereol Suppl (Stockh); 1989; 143():35-9. PubMed ID: 2528257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of facial acne scars by the 585 nm flashlamp-pumped pulsed dye laser.
    Alster TS; McMeekin TO
    J Am Acad Dermatol; 1996 Jul; 35(1):79-81. PubMed ID: 8682969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional resurfacing for the treatment of atrophic facial acne scars in asian skin.
    Hu S; Chen MC; Lee MC; Yang LC; Keoprasom N
    Dermatol Surg; 2009 May; 35(5):826-32. PubMed ID: 19397671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of topical retinoid therapy on seborrhea using iontophoresis].
    Knor T
    Med Arh; 2003; 57(5-6):295-8. PubMed ID: 15022582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical retinoic acid in the treatment of fine acne scarring.
    Harris DW; Buckley CC; Ostlere LS; Rustin MH
    Br J Dermatol; 1991 Jul; 125(1):81-2. PubMed ID: 1831384
    [No Abstract]   [Full Text] [Related]  

  • 20. Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial.
    Dreno B; Tan J; Rivier M; Martel P; Bissonnette R
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):737-742. PubMed ID: 27790756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.